YY/T 1578-2018Glycated albumin assay kit(enzymatic method) (English PDF)
糖化白蛋白测定试剂盒(酶法)
This is a limited preview
Buy now to download the full PDF (15 pages)
Need quotation for your management?
Get a formal quotation for YY/T 1578-2018 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
February 24, 2018
Implementation date
March 1, 2019
Scope
YY/T 1578-2018 is the English-translated version of 糖化白蛋白测定试剂盒(酶法).
YY/T 1578-2018 is the Chinese pharmaceutical industry standard for the glycated albumin assay kit based on the enzymatic method, the test that shows the average blood glucose of the past two to three weeks.
It sets the requirements, the test methods, the labels and instruction manual and the rules for packaging, transport and storage, covering the appearance, the blank absorbance, the traceability of the calibrator, accuracy, linearity, the detection limit, precision, interference and stability. Issued on 24 February 2018, it has applied since 1 March 2019.
Found what you need?
Document preview — YY/T 1578-2018
National Standard of the People's Republic of China
Issued by: National Medical Products Administration of the People's Republic of China
Contents
- Foreword3
- 1 Scope4
- 2 Normative references4
- 3 Requirements4
- 4 Test method6
- 5 Labels and operating instructions10
- 6 Packaging, transportation and storage10
1 Scope
This standard specifies the requirements, test methods, labeling and instruction manuals, packaging, transportation and storage requirements for glycated albumin assay kits.
This standard applies to the use of enzymatic kits for quantitative detection of glycated albumin in human serum or plasma, including reagents used on manual and semi-automatic, fully automatic biochemical analyzers.
If the glycated albumin assay kit contains the albumin test component, the technical requirements of the albumin assay reagent refer to the corresponding standards.
2 Normative references
The following documents are essential to the application of this document. For the dated documents, only the versions with the dates indicated are applicable to this document; for the undated documents, only the latest version (including all the amendments) are applicable to this standard.
GB/T 29791.2 In vitro diagnostic medical devices - Information supplied by the manufacturer (labelling) - Part 2: In vitro diagnostic reagents for professional use
3 Requirements
3.1 Appearance
The appearance of the assay kit shall meet:
a) The components of the assay kit shall be complete and intact, with no leakage of liquid;
b) The text symbols on the packaging labels shall be clear.
3.2 Loading
It shall not be less than the marked value. greater than 15%. The 95% of the test samples shall meet the above requirements.
3.8 Stability
3.8.1 General
It may verify the stability of the expiration date and thermal stability.
3.8.2 Validity period stability
The manufacturer shall specify the validity period of the product. After taking the product within a certain period of time, the detection reagent's blank absorbance, analytical sensitivity, linearity, repeatability, accuracy shall meet the requirements of 3.3, 3.4, 3.5, 3.6.1, 3.7.
3.8.3 Thermal stability test
The detection reagent's blank absorbance, analytical sensitivity, linearity, repeatability, accuracy shall meet the requirements of 3.3, 3.4, 3.5, 3.6.1, 3.7.
Note 1: Thermal stability cannot be used to derive the product expiration date, unless a derivation formula based on a large amount of stability study data is used.
Note 2: In general, when the products have a validity period of 1 year, select products of not more than 1 month; when the products have a validity period of half a year, select products of not more than half a month, and so on. But if it exceeds the specified time, the product can also be accepted when it meets the requirements.
Note 3: According to the product characteristics, it may select any combination of methods of 3.8.2 and 3.8.3, but the selected method should be able to verify the stability of the product, to ensure that the product performance meets the standard requirements during the validity period.
4 Test method
4.1 Basic requirements for instruments and materials
4.1.1 Spectrophotometer or biochemical analyzer, whose wavelength range shall meet the needs of reagents. The biochemical analyzer shall be equipped with a constant temperature device (the temperature value is within ± 0.3 °C of the set value, the fluctuation is not more than ± 0.2 °C); the resolution of the absorbance measurement is above 0.001.
4.1.2 The albumin concentration of the samples used in 4.5 ~ 4.7 is 40 g/L ~ 50 the method of relative deviation is preferred.
4.8.2 Relative deviation
The kit test can be used to evaluate the certified reference material (CRM) of conventional methods or other recognized reference materials 3 times, the test result is recorded as (Xi). Use the formula (4) to respectively calculate the relative deviation Bi. If the results of the 3 tests meet the requirement of 3.7a), it is judged as qualified. If more than or equal to 2 test results does not match, it is judged as unqualified. If one of the results does not meet the requirements, it shall re-test 20 times in succession; calculate the relative deviation according to equation (4) respectively. If the results of 19 or more tests meet the requirements of 3.7a), the accuracy meets the requirements of 3.7a).
Where: Bi - Relative deviation; Xi - Measured concentration; T - Reference substance's calibration concentration.
4.8.3 Comparison test
Use no less than 40 human source samples covering different concentrations within the detection concentration range, to conduct a comparison test by a traceability analysis system designated by the manufacturer. Each sample is tested separately according to the requirements of the reagent kit to be tested and the selected analysis system. Each sample is measured once; the two sets of results are linearly fitted using the linear regression method, to obtain the correlation coefficient (r) and slope of the linear regression equation. Calculate the absolute deviation or relative deviation of the measured value of the test kit of each sample and the measured value of the control system, which shall meet the requirements of 3.7b).
4.9 Stability
4.9.1 Validity period stability
The samples beyond the validity period are taken shall be tested according to the methods of 4.4, 4.5, 4.6, 4.7.1, 4.8, which shall meet the requirements of 3.8.2.
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 15 pages — is available in the English PDF.
Referenced standards
Similar standards
How to Download YY/T 1578-2018
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 29791.2-2013 — In vitro diagnostic medical devices -- Information supplied by the manufacturer (labelling) -- Part 2: In vitro diagnostic reagents for professional use
YY/T 0297-2026 — General requirements for clinical investigation of medical devices
YY/T 0479-2026 — Medical diagnostic X-ray tube assemblies and X-ray source assemblies - Determination of maximum symmetric radiation field
Secure payment via Stripe
Payments accepted
YY/T 1578-2018
$105.00